Louvina van der Laan

13PUBLICATIONS
28CO-AUTHORS
PharmacogenomicsInfant and child healthEpidemiological modellingNutritional epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Aug 13, 2026
Pharmacokinetics and Safety of a Novel Clofazimine Formulation and Dosing Strategy in Children With Rifampicin-resistant Tuberculosis.

|Jan 08, 2026
Dolutegravir concentrations in children receiving 3-month weekly isoniazid and rifapentine (3HP) for tuberculosis prevention.

Ruvarashe J Madzime, Louvina van der Laan, Samantha du Toit

|May 29, 2025
Population pharmacokinetics and dosing of dispersible moxifloxacin formulation in children with rifampicin-resistant tuberculosis.

Megan Palmer, Yuanxi Zou, Anneke C Hesseling

|Feb 17, 2025
Population pharmacokinetics and dosing of dispersible moxifloxacin formulation in children with rifampicin-resistant tuberculosis.

Megan Palmer, Yuanxi Zou, Anneke C Hesseling

|Feb 11, 2025
Pharmacokinetics and Safety of Clofazimine in Children With Rifampicin-Resistant Tuberculosis.

Jennifer A Hughes, Belén P Solans, Anthony J Garcia-Prats

|Dec 28, 2024
Model-Informed Once-Daily Dosing Strategy for Bedaquiline and Delamanid in Children, Adolescents and Adults with Tuberculosis.

Yu-Jou Lin, Louvina E van der Laan, Mats O Karlsson

Pageof 3

Frequent Collaborators

11 joint publications

Anthony J Garcia-Prats

7 joint publications

Lubbe Wiesner

7 joint publications

Paolo Denti

5 joint publications

Belén P Solans